Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety, efficacy and pharmacokinetics of teduglutide in 4- to 12-month-old infants with Short Bowel Syndrome; results completed and post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2021-04-08